Literature DB >> 12192406

Mantle compensation of active metamorphic core complexes at Woodlark rift in Papua New Guinea.

Geoffrey A Abers1, Aaron Ferris, Mitchell Craig, Hugh Davies, Arthur L Lerner-Lam, John C Mutter, Brian Taylor.   

Abstract

In many highly extended rifts on the Earth, tectonic removal of the upper crust exhumes mid-crustal rocks, producing metamorphic core complexes. These structures allow the upper continental crust to accommodate tens of kilometres of extension, but it is not clear how the lower crust and underlying mantle respond. Also, despite removal of the upper crust, such core complexes remain both topographically high and in isostatic equilibrium. Because many core complexes in the western United States are underlain by a flat Moho discontinuity, it has been widely assumed that their elevation is supported by flow in the lower crust or by magmatic underplating. These processes should decouple upper-crust extension from that in the mantle. In contrast, here we present seismic observations of metamorphic core complexes of the western Woodlark rift that show the overall crust to be thinned beneath regions of greatest surface extension. These core complexes are actively being exhumed at a rate of 5-10 km Myr(-1), and the thinning of the underlying crust appears to be compensated by mantle rocks of anomalously low density, as indicated by low seismic velocities. We conclude that, at least in this case, the development of metamorphic core complexes and the accommodation of high extension is not purely a crustal phenomenon, but must involve mantle extension.

Entities:  

Year:  2002        PMID: 12192406     DOI: 10.1038/nature00990

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1 in total

1.  Identification and localization of Nup170 in the microsporidian Nosema bombycis.

Authors:  Ruisha Shang; Feng Zhu; Yu Li; Ping He; Jingru Qi; Yong Chen; Fuzhen Sun; Yiling Zhang; Qiang Wang; Zhongyuan Shen
Journal:  Parasitol Res       Date:  2021-03-26       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.